Search results
Dr. Loh: Brand name medications vs. generics: Are they really the same?
VC Star | Ventura County Star via Yahoo News· 8 months agoI have been a clinical researcher for almost 50 years. After medical school and internal medicine...
Q1 2024 Schrodinger Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 month agoParticipants Jaren Madden; Senior Vice President, Investor Relations & Corporate Communications; Schrodinger Inc Ramy Farid; President, Chief Executive Officer, Director; Schrodinger Inc Geoffrey ...
'I couldn't even see out of it': KY woman suing manufacturers amid eye drop recall
The Courier Journal via Yahoo News· 7 months agoWhen Judith Gregory’s left eye became red, teary and painful last year, she made the first of many...
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoSchrödinger, Inc. (NASDAQ:SDGR) Q1 2023 Earnings Call Transcript May 4, 2023 Operator: Thank you for...
Q1 2024 Aptargroup Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 month agoParticipants Marry Skafidas; SVP of IR & Communications; AptarGroup, Inc. Robert W. Kuhn; Executive VP & CFO; AptarGroup, Inc. Stephan B. Tanda; President, CEO & Executive Director; AptarGroup ...
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings
Zacks via Yahoo Finance· 1 year agoShares of Ligand Pharmaceuticals Incorporated LGND rose 3.4% on Friday in response to the company’s...
First Advantage Corporation (NASDAQ:FA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoFirst Advantage Corporation (NASDAQ:FA) Q4 2023 Earnings Call Transcript March 1, 2024 First...
Adverum (ADVM) Completes IND Amendment for Gene Therapy Study
Zacks via Yahoo Finance· 2 years agoAdverum (ADVM) completes IND amendment with the FDA for initiating the phase II LUNA study on its...
These 2 Penny Stocks Are Poised for a Big Rally, Says Oppenheimer
TipRanks via Yahoo Finance· 2 years agoDoes high risk mean high reward? Not necessarily, so say the pros on Wall Street. Specifically...
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoInnate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A....